Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Vera Therapeutics Inc did not generate a significant amount of cash. Cash Flow from Financing totalled 133.54m or -- of revenues. In addition the company used 92.18m for operations while cash used for investing totalled 39.43m.
Cash flow per share | -1.57 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 5.25 |
---|---|
Tangible book value per share | 5.25 |
More ▼
Balance sheet in USDView more
Current ratio | 13.76 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.1746 |
---|---|
Total debt/total capital | 0.1487 |
More ▼